This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ares Capital Corporation, as Agent. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Marcus R Duvall
Introduction
Marcus R Duvall is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of synthetic biology, particularly in the area of gene assembly and error reduction. His work has implications for various applications in biotechnology and genetic engineering.
Latest Patents
Marcus holds a patent titled "Assembly and Error Reduction of Synthetic Genes from Oligonucleotides." This patent addresses challenges in the synthesis of synthetic genes, providing innovative solutions to enhance accuracy and efficiency in gene assembly.
Career Highlights
Marcus is currently employed at Ares Capital Corporation as an Agent. His role involves leveraging his expertise in synthetic biology to contribute to the company's innovative projects. His background and knowledge in the field have positioned him as a valuable asset to his team.
Collaborations
Throughout his career, Marcus has collaborated with notable colleagues, including Kevin Smith and Robin Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Marcus R Duvall's contributions to synthetic biology through his patent and career at Ares Capital Corporation highlight his role as a leading inventor in the field. His work continues to influence advancements in biotechnology and genetic engineering.